THURSDAY, Dec. 19, 2019 (American Heart Association News) -- Remembering to drink enough water is easy during the summer, when higher temperatures and outdoor activities drive the point home. But staying adequately hydrated is just as important during the winter.
Environmental humidity plays a role, said Stavros Kavouras, who directs the Hydration Science Lab at Arizona State University in Phoenix. Central heating causes drier interior environments during the winter, which can lead to increased water loss simply from breathing.
FRIDAY, Nov. 15, 2019 -- Antibacterial drug Fetroja (cefiderocol) has been approved to treat patients aged 18 years and older with complicated urinary tract infections (cUTIs), the U.S. Food and Drug Administration announced yesterday.
The drug is indicated for patients with limited or no alternative treatment options for cUTI, including kidney infections caused by susceptible Gram-negative microorganisms. Dosage is 2 g of Fetroja every eight hours administered by intravenous infusion over three hours. Dose adjustments are required based on creatinine clearance. Prescription labeling on Fetroja includes a warning for a higher all-cause mortality rate in Fetroja-treated critically ill patients with multidrug-resistant Gram-negative bacterial infections.